Beyond their effectiveness in glycemic control, these therapies also promote weight loss, making them beneficial for patients with overweight or obesity alongside type 2 diabetes
28% contained instructional text
Many insurance providers now cover Wegovy for weight loss due to its clinical efficacy
This study reports that people who are more interested in GLP-1 medications and more willing to tolerate its negative side effects have higher levels of body dissatisfaction and shame, more bias against fat people, and more disordered eating behaviors
The key strengths of our study are the large, comprehensive source of real-world data available and the robust study design
EUROPAC-2 is a three-armed trial involving a potent commercial preparation of the antioxidant combination (Antox version 1.2, Pharmanord, UK), versus magnesium , versus placebo in patients with hereditary or idiopathic disease